dalteparin has been researched along with Myringosclerosis in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Myringosclerosis: The formation of dense connective tissue in the TYMPANIC MEMBRANE that does not necessarily cause or lead to loss of hearing.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilge, A | 1 |
Gunes, A | 1 |
Dagli, M | 1 |
Koybasioglu, FF | 1 |
Guvey, A | 1 |
Ayata, M | 1 |
Kaptan, Z | 1 |
Uzunkulaoğlu, H | 1 |
Akyıldız, İ | 1 |
Tüzüner, A | 1 |
Ünverdi, H | 1 |
Karadaş, H | 1 |
2 other studies available for dalteparin and Myringosclerosis
Article | Year |
---|---|
The impact of topical and systemic enoxaparin sodium use on traumatic tympanic membrane perforation and myringosclerosis.
Topics: Administration, Topical; Animals; Anticoagulants; Craniocerebral Trauma; Enoxaparin; Injections, Sub | 2016 |
Effect of Enoxaparin Sodium on Experimentally-Induced Myringosclerosis in Rats.
Topics: Animals; Anticoagulants; Calcinosis; Disease Models, Animal; Enoxaparin; Fibrosis; Hyalin; Hyperemia | 2015 |